SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-022572
Filing Date
2022-08-15
Accepted
2022-08-15 07:24:19
Documents
66
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1847984
2 ex31-1.htm EX-31.1 16099
3 ex32-1.htm EX-32.1 9349
  Complete submission text file 0001493152-22-022572.txt   7631947

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bixt-20220630.xsd EX-101.SCH 48803
5 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bixt-20220630_cal.xml EX-101.CAL 46632
6 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bixt-20220630_def.xml EX-101.DEF 214493
7 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bixt-20220630_lab.xml EX-101.LAB 378038
8 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bixt-20220630_pre.xml EX-101.PRE 317043
60 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1509943
Mailing Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494
Business Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494 617-494-1199
BIOXYTRAN, INC (Filer) CIK: 0001445815 (see all company filings)

IRS No.: 262797630 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35027 | Film No.: 221162319
SIC: 2834 Pharmaceutical Preparations